Aptamer Sciences Inc (KOSDAQ: 291650)
South Korea
· Delayed Price · Currency is KRW
2,970.00
+565.00 (23.49%)
Oct 11, 2024, 9:00 AM KST
Aptamer Sciences Company Description
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.
The company’s aptamer platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics.
It offers AlloMAp and BiFAp platform programs for therapeutics; and diagnosis kits for lung and pancreatic cancer, as well as in-vitro diagnostic kits for the early diagnosis of lung cancer.
Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea.
Aptamer Sciences Inc
Country | South Korea |
Founded | 2011 |
Industry | Biological Products, Except Diagnostic Substances |
CEO | Dongil Han |
Contact Details
Address: 407 Ho, Healthcare Innovation Park Seongnam, 13605 South Korea | |
Phone | 82 3 1786 0317 |
Website | aptsci.com |
Stock Details
Ticker Symbol | 291650 |
Exchange | KOSDAQ |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dongil Han | Chief Executive Officer |
CheolHwan Lee | Chief Financial Officer |